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Although epidural spinal stimulation (ESS) results in promising therapeutic effects in
individuals with spinal cord injury (SCI), its potential to generate functional motor recovery
varies between individuals and remains largely unclear. However, both preclinical and
clinical studies indicate the capacity of electrical and pharmacological interventions to
synergistically increase the engagement of spinal sensorimotor networks and regain
motor function after SCI. This study explored whether selective pharmacological
antagonism of the adenosine A1 receptor subtype synergizes with ESS, thereby
increasing motor response. We hypothesized that selective pharmacological antagonism
of A1 receptors during ESS would produce facilitatory effects in spinal sensorimotor
networks detected as an increased amplitude of spinally-evoked motor potentials
and sustained duration of ESS induced activity. Terminal experiments were performed
in adult rats using trains of stereotyped pulses at 40 Hz delivered at L5 with the
local administration to the cord of 8-cyclopentyl-1,3-dipropylxanthine (DPCPX). We
demonstrated that ESS combined with the blockage of A1 receptors increased the
magnitude of the endogenous modulation and postponed the decay of responses that
occur during ESS alone. Although DPCPX significantly increased the yield of repetitive
stimulation in intact spinal cords, the effects of A1 antagonism on motor evoked
responses after an acute spinal transection was not detected. These studies support
the future investigation of the optimal dosage, methods of delivery, and systemic effects
of the synergistic application of A1 antagonists and spinal stimulation in the intact and
injured spinal cord.
Keywords: motor control, spinal electrical stimulation, spinal reflexes, adenosine receptors, spinal transection,
trains of pulses, terminal recordings
Abbreviations: ATP, adenosine triphosphate; ANOVA, analysis of variance; CNS, central nervous system; EMG,
electromyogram; ESS, epidural spinal stimulation; GM, gastrocnemius; i.p., intraperitoneal; l, left; L, lumbar; SCI, spinal
cord injury; SD, standard deviation; TA, tibialis anterior; Th, thoracic; DPCPX, 8-cyclopentyl-1,3-dipropylxanthine; DMPX,
3,7-dimethyl-1-propargylxanthine.
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INTRODUCTION
Recent results from preclinical animal models and pilot
phase clinical trials applying spinal neuromodulation have
revealed that neural networks below the site of spinal cord
injury (SCI) retain functional capabilities. Further, when
electrically stimulated, neural networks can be reorganized to
generate responses and motor activities previously thought
to be permanently lost due to paralysis (Edgerton et al.,
2008; Courtine et al., 2009; Fong et al., 2009; Rossignol
and Frigon, 2011). Notably, epidural spinal stimulation (ESS)
during activity-based rehabilitative therapy recovers previously
paralyzed motor functions, improves autonomic nervous system
functionality, and enhances well-being for those living with
chronic paralysis due to SCI (Harkema et al., 2011; Angeli
et al., 2014; Phillips and Krassioukov, 2015; Aslan et al.,
2016, 2018; Grahn et al., 2017; Rejc et al., 2017; Herrity
et al., 2018; Darrow et al., 2019). However, the level of
functional performance regained following ESS therapy varies
to a great extent, with the emergence of self-assisted stepping
in a subset of trained individuals being the most advanced
outcome to date (Angeli et al., 2018; Gill et al., 2018; Wagner
et al., 2018). Variability in ESS efficacy likely results from
unaccounted neurophysiological profiles among individuals,
varying degrees of maladaptive neural plasticity, differences in
training regimens, and/or high variation in spared neurologic
function even within one grade of SCI severity. Given the
variable effectiveness of ESS, studies that illuminate synergistic
approaches (e.g., pharmacological agents) and mechanisms
regulating the excitability of motor networks are needed to
significantly impact the effectiveness of ESS therapy. Previous
experiments in rats and cats have explored combination
strategies, synergizing ESS with monoaminergic agents (e.g.,
clonidine, cyproheptadine, or levodopa; Courtine et al., 2009;
Musienko et al., 2011) or non-competitive blockers (e.g.,
strychnine; de Leon et al., 1999). These works demonstrated
that the spinal motor infrastructure is composed of a widely
distributed and heterogeneous system of neural circuits and
receptors that can generate a range of task-specific movements
when recruited in different combinations (Tresch and Bizzi,
1999; Hochman et al., 2001; Courtine et al., 2009). However,
researchers were unable to translate these results to the
clinic, as the administration of buspirone, a serotonin agonist,
produced mixed or moderate improvements (Gerasimenko
et al., 2015; Gad et al., 2017; Freyvert et al., 2018). Therefore,
there is a need to explore alternative pharmacological targets
for more effective pharmacological neuromodulation, such
as adenosine receptors (Bai et al., 2017). Adenosine is an
endogenous purinergic autocoid with well-known vascular
and anti-inflammatory effects (Layland et al., 2014). In the
central nervous system (CNS), adenosine is synthesized by the
hydrolysis of adenosine triphosphate (ATP) and then locally
released by neurons and astrocytes in the synaptic cleft, where
adenosine has a short half-life. Two receptors for adenosine
(A1, A2) are reported in the CNS. While A1 is coupled to
an inhibitory Gi protein, A2s (A2A and A2B) are associated
with a stimulating Gs (Burnstock, 2007). The majority of
A1 receptors are located presynaptically, mediating inhibition
on neurotransmitter release (Fisone et al., 2004). Acting via
A1 receptors, adenosine modulates ventral motoneurons (Witts
et al., 2015) and acts on spinal motor networks as an intrinsic
modulator, providing negative feedback that controls the activity
generated by the spinal locomotor circuitry (Witts et al.,
2011; Taccola et al., 2012; Acton and Miles, 2015). Moreover,
primary afferents co-release ATP and glutamate on spinal
synapses, where the resulting adenosine acts on presynaptic
A1 autoreceptors to limit the flow of external input from
the periphery (Burnstock and Wood, 1996). This endogenous
neuromodulator inhibits afferent input from the periphery
through A1 adenosine receptor subtypes, as indicated by
modulation of nociceptive pathways with adenosinergic agents
(Reeve and Dickenson, 1995).
An increase of endogenous adenosine during electrical
stimulation has been reported arising from neuronal and glial
cells (Caciagli et al., 1988; Tawfik et al., 2010). Peripheral
stimulation of primary sensory afferents also releases adenosine
in the spinal cord (Salter and Henry, 1987). During ESS,
primary afferents are inevitably recruited and the released
adenosine is a potential impediment to the yield of electrical
stimulation. Indeed, A1 adenosine receptors may limit the
inflow of electrical inputs, suggesting that the use of competitive
antagonists for A1 adenosine receptors could facilitate the
transit of electrical stimuli to neuronal networks in the
spinal cord. As such, the effectiveness of electrical stimulation
in recruiting a wider range of the spinal circuitry can
be amplified, thus, maximizing plasticity and recovery of
sensorimotor functions. Efficacy of A1 adenosine antagonists
on spinal sensorimotor circuits has been studied on in vitro
spinal cord preparations (Taccola et al., 2012), where it
was demonstrated that activation of A1 adenosine receptors
modulates the interneuronal networks responsible for the
generation of locomotor behavior (Witts et al., 2011, 2015;
Taccola et al., 2012; Acton and Miles, 2015). However,
the effects of A1 adenosine antagonists on the modulation
of spinally-evoked motor responses during ESS in vivo are
currently unknown. The objective of this work is to explore
whether the selective pharmacological antagonism of the subtype
A1 adenosine receptors can synergize with ESS to increase spinal
excitability and motor responses induced by spinal electrical
stimulation. We hypothesized that the presence of A1 adenosine
antagonists during spinal electrical stimulation would produce
facilitatory effects in spinal sensorimotor networks, as revealed
by increased amplitude of spinally-evoked motor potentials
and sustained duration of the spinal electrical stimulation-
induced activity. For this, we applied the A1 antagonist
8-cyclopentyl-1,3-dipropylxanthine (DPCPX) directly to the
spinal cord of adult rats during supra-motor threshold
ESS and assessed the neuromodulatory effects of DPCPX
on spinally-evoked motor potentials. Although A2 receptors
have been considered functionally marginal for the spinal
sensorimotor circuits (Geiger et al., 1984), the A2 antagonist,
3,7-dimethyl-1-propargylxanthine (DMPX) was also tested in
our study to explore any potential modulation of motor output
evoked by ESS.
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MATERIALS AND METHODS
Experimental Design
All procedures were approved by the Institutional Animal Care
and Use Committee at Houston Methodist Research Institute.
Further, they were in accordance with both the guidelines of the
National Institutes of Health (NIH) Guide for the care and use of
laboratory animals and the European Union directive on animal
experimentation (2010/63/EU). Adult Long-Evans rats (female,
300–350 g body weight; Charles River Long-Evans, Houston, TX,
USA) were anesthetized by intraperitoneal (i.p.) administration
of ketamine (100 mg/Kg) and xylazine (5 mg/Kg) mix and
terminal electrophysiological recordings were obtained. During
each experiment, toe pinches were performed periodically to
assess whether the anesthetic level was maintained. If animals
exhibited a reflex, a booster of ketamine was administered, as
needed. Additionally, animals were kept under anesthesia over
a heating pad (37◦C) throughout each experiment. Finally, at the
end of all experiments (2–3 h), animals were euthanized by CO2
followed by cervical dislocation or thoracotomy.
A cartoon schematizing the experimental design of the study
is provided in Figure 1A. Briefly, two main experimental groups
were included: rats with intact spinal cords (n = 8) and rats
with transected spinal cords (n = 6). After collecting baseline
recordings to serve as internal controls for each animal, the
intact cord group was further split to explore the effects of
DPCPX (n = 5) or DMPX (n = 3) applications. The transected
group was also further divided into those exposed to DPCPX
(n = 5, similar to the intact-DPCPX group) and sham control
(n = 1). For the sham control animal, trains of pulses were
regularly supplied as in the treated groups, albeit without the
presence of any substances. The tests demonstrated the stability
of baseline responses for the entire length of a recording session
after acute spinal transection (50 min). This feature is illustrated
in Figure 1B, as the unchanged main amplitude of spinal
reflexes, pooled from bilateral tibialis anterior (TA) and left
gastrocnemius (GM) muscles, in responses to the serial delivery
of 40 Hz trains every 5 min, to mimic the stimulation rate
provided during real experiments [P = 0.490, Friedman repeated-
measures analysis of variance (ANOVA) on ranks, n = 3].
The prototypic experimental design is schematized in
Figure 1C. After a 15 min wait for the full induction
of anesthesia, surgical procedures were performed (lasting
approximately 1 h) for laminectomy, as well as epidural and
EMG electrode implantations. Where appropriate, a complete
transection of the spinal cord was performed as soon as
the cord was exposed (30 min). After surgery, the second
injection of ketamine was administered followed by a rest period
(15 min) that was required to achieve stable conditions. Then,
electrophysiological recordings began by first placing EMG
electrodes and exploring the threshold intensity of epidural
stimulation and then by delivering three single rectangular pulses
(100 µs, duration) at increasing intensities (0.1 mA increments)
with an interstimulus interval of 5 s. Motor threshold intensity
was defined in each animal as the lowest intensity to elicit
consistent EMG responses in a given muscle, as revealed by visual
inspection of waveforms on the computer monitor. The operative
suprathreshold amplitude of stimulation (range of 0.4–2 mA)
was selected for each animal to evoke responses in all recorded
muscles during the experiments (usually equal to 0.1 mA over the
threshold value). The stability of threshold responses was verified
every 5 min, 2 min after each new application. After the threshold
definition, the experiments started (40–45 min) by delivering a
train of 2,000 pulses at 40 Hz every 5 min. To define baseline
conditions, three trains (40 Hz) were firstly supplied before the
local application of drugs on the cord. Then, chemicals (DPCPX
or DMPX) were applied every 5 min at increasing concentrations
(1–100 µM) and the trains were repeated every 5 min before a
new concentration was applied.
Intramuscular Electromyogram (EMG)
Electrode Implantation
EMG signals from bilateral TA and left GM muscles were
derived from belly muscles using 13 mm paired subdermal
needle electrodes (0.4 mm diameter, RLSND121-1.5, Rhythmlink
Colombia, SC, USA) inserted through the shank skin. A ground
electrode was placed subcutaneously on the left forearm. Before
starting the experiment, proper placement of electrodes was
confirmed by the motion artifact generated when tapping the
muscle. EMG recordings were amplified (gain 1000, range
0.1 Hz to 1 kHz, and notched at 60 Hz) using a differential
AC amplifier (DP-304A, Warner Instruments, Hamden, CT,
USA) and subsequently digitalized at 40 kHz (PowerLabr,
ADInstruments Pvt. Ltd., Bella Vista, NSW, Australia).
Epidural Electrode Implantation and
Stimulating Protocol
After a partial laminectomy between thoracic (Th)12/Th13 and
the complete removal of lumbar (L)1 lamina, two multistrand,
Teflon-coated stainless-steel wires (AS 632, Cooner Wire Co,
Chatsworth, CA, USA) was slid through the small opening at
Th12/ Th13 up to L2. A small notch (0.5–1.0 mm) in each
wire was deprived of insulation at L1 vertebral level (L5 spinal
segment) to expose the conductor and form the electrodes,
which were then placed on each side of the dorsal cord (1 mm
laterally from the midline). The two wires were used as cathode
and anode for bipolar stimulation. Single or repetitive current
pulses (duration 100 µs) were supplied to the cord using a
DS8R constant-current stimulator (Digitimer, UK). Trains of
2,000 stereotyped rectangular pulses at 40 Hz (interstimulus
interval of 25 ms, the total time of the train of 50.2 s) were
delivered every 5 min.
Experimental Spinal Cord Transection and
Drug Application
An acute complete transection of the cord was performed in five
animals at the upper thoracic level (vertebrae Th8 to Th11) using
a pair of iridectomy scissors. The resulting gap was inspected by
another expert surgeon and filled by a small cotton ball for the
entire duration of the experiment. DPCPX (Cat. N. 0439/100,
R&D Systems Inc., Minneapolis, MN, USA) and DMPX (Cat.
N. D134, Sigma-Aldrich, St. Louis, MO, USA) were locally
applied to the cord by diluting each drug in 500 µl of the saline
medium. In four out of 14 experiments, before adding the two
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FIGURE 1 | Experimental design and analysis. (A) The cartoon schematizes the number of animals used in the study with the corresponding experimental
protocols. Animals with transected spinal cords are represented by crossed bodies. (B) Mean peak amplitude, expressed as a percentage of the first delivered train,
is shown in the graph for all consecutive trains applied for the whole duration of a standard experiment (one train per 5 min). The values of the amplitude of
electromyogram (EMG) responses are averaged from three muscles of the same animal that received consecutive stimulations without any drug application (sham).
Error bars represent standard deviation (SD). (C) A prototypical experiment is described in its different phases (see details in the “Materials and Methods” section).
(D) The scheme draws the procedure to quantify the rhythmic pattern modulating the amplitude of electrically-induced EMG responses during the delivery of 40 Hz
trains (see “Materials and Methods” for more details).
pharmacological agents, the dura was opened with a longitudinal
incision along the midline of the entire spinal segment L5
(leaving the dura intact under the two electrodes). Given that
no difference in drug effect was found when the dura remained
intact compared to when it was not intact, data were pooled
from both groups. This observation confirmed previous reports
on the full permeability of the spinal dura to the substances
used in the current study (Nantwi and Goshgarian, 2002). The
effects of pharmacologic agents were determined by comparison
with internal control for each animal. Specifically, responses in
DPCPX or DMPX were compared to the baseline responses
collected in the same animals before the application of drugs.
Data Analyses
Amplitude and latency (defined at the first deflection of
baseline) of all EMG responses were determined using Labchartr
version 8 (ADInstruments, Australia) and Clampfitr version
10.3 software (Molecular Devices, San Jose, CA, USA). The
amplitude of all consecutive responses evoked by each train was
plotted for each muscle as time-course graphs. In the animals in
which simultaneous recordings were obtained from bilateral TA
and left GM, all muscles showed equal responses as for latency
(P = 0.567, one-way repeated measures ANOVA; n = 5) and
peak to peak amplitude (P = 0.059, one-way repeated measures
ANOVA; n = 5). The amplitude of suprathreshold responses in
bilateral TAs and left GMs did not differ across muscle groups
or among tested animals. Therefore, values were first averaged
among different muscles in response to the same train, then
averaged among repetitions from the same experiment, and
finally pooled among different animals for statistical comparison
between treatments. The sum of amplitude responses was
calculated from raw values to obtain the mean cumulative
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amplitude for each treatment. To identify whether spontaneous
variations in the peaks of responses followed a rhythmic pattern
of modulation, the procedure schematized in Figure 1D was
performed. In brief, the linear profile connecting the peaks
of the time-course of electrically induced EMG responses was
handled as a continuous waveform, with the sampling period
(25 ms) equal to the interstimulus interval at the frequency of
stimulation (40 Hz). The intrinsic modulatory rhythm of the
amplitude of EMG reflexes was quantified in terms of power
spectrum magnitude and expressed as Root Mean Square (RMS;
Deumens et al., 2013), measured with Clampex 10.3r (Molecular
Devices Corporation, Downingtown, PA, USA). The analysis
adopted a default rectangular windowing function, with data
segments not overlapping, window length set at the largest
value fitting within the data segments to be processed, and
the first spectral bin of the periodogram excluded from RMS
measurements. The magnitude of the resulting spectrum is the
summed power of all rhythm frequencies. This statistical tool
quantifies any increase in frequency and/or amplitude of EMG
evoked-responses, expressed as a complex rhythm composed of
multiple harmonics.
Statistical Analysis
Data are indicated as mean ± standard deviation (SD)
values and n refers to the number of rats used. The
normality of data distribution was determined based on a
Kolmogorov–Smirnov normality test. Statistical analysis was
performed using SigmaStatr version 3.5 software (Systat
Software, San Jose, CA, USA) to compare the mean ± SD
of different experimental conditions. All parametric values
were analyzed using a two-tailed Student’s t-test (paired or
unpaired) to compare two groups of data or a one-way ANOVA
for more than two groups. Nonparametric comparisons were
performed using the Mann–Whitney rank-sum test (unpaired)
and Wilcoxon signed-rank test (paired) for two groups and
Kruskal–Wallis ANOVA for more than two groups. Friedman
repeated-measures ANOVA on ranks was performed for
multiple comparisons. Multiple comparisons were followed by
post hoc tests (Dunn’s Method). Results reached significance
when P < 0.05.
RESULTS
Train Pulse Delivery Elicited EMG
Responses That Were Spontaneously
Modulated in Amplitude
In eight intact animals, electrical stimulation of the cord
(intensity = 0.71 ± 0.26 mA) evoked control suprathreshold
responses with a mean latency of 5.46 ± 0.77 ms and a
mean peak to peak amplitude equal to 0.57 ± 0.45 mV. In
Figure 2A, sample traces from three hindlimb muscles represent
the first ten responses elicited by a train of rectangular pulses
(100 µs) at 40 Hz applied to the cord at the L5 spinal
segment (Th13/L1 vertebrae). The amplitude of consecutive
motor reflexes varied from large to minimal (up to occasional
abolishment) responses. A longer train of pulses (2,000 pulses at
40 Hz) elicited responses varying in amplitude throughout the
entire protocol, as summarized by the average time-course of
the peak amplitudes from five experiments (Figure 2B). Motor
responses consistently faded away during the first 300 pulses
(7.5 s of stimulation; Figures 2B,C) with a dramatic reduction
occurring after the 1,800th pulse (45 s of stimulation) under
continuous stimulation at a given intensity (Figure 2D). A brief
rest was sufficient to reinstate full response, as evidenced by
the equal values of the cumulative amplitude of all 2,000 motor
reflexes evoked by two consecutive trains spaced 5 min apart
(96.64 ± 16.77%; P = 0.132, paired t-test, t = 1.703; n = 8).
To identify if the spontaneous variation of responses followed a
particular rhythmic pattern of modulation, the mean time-course
of peaks were analyzed using power spectral analysis (Figure 2E;
n = 5). A rhythmic component centered around 1.41 ± 0.69 Hz
and with an amplitude of 0.0017 ± 0.0011 mV/Hz2 described
the presence of a spontaneous rhythmic pattern of modulation
with a power spectrum magnitude, expressed as RMS equal to
0.20± 0.13, n = 5.
These data indicate that continuous epidural stimulation with
a train of pulses at 40 Hz produces EMG responses that are
intrinsically modulated in amplitude by a spontaneous oscillatory
rhythm of a lower frequency than the one supplied by the
stimulating pattern.
The Selective A1 Competitive Antagonist,
DPCPX, Maximizes Electrical Stimulation
To evaluate whether the selective pharmacological blockade
of the A1 adenosine receptor subtype affects spinal cord
stimulation, trains of 2,000 pulses (40 Hz) were serially delivered
during increasing concentrations of the selective antagonist
DPCPX (1–100 µM). The application of DPCPX at any dosage
did not cause spontaneous activity in the muscles. The lowest
concentration tested (1 µM) did not affect the cumulative
amplitude of responses (DPCPX 1 µM = 134.46 ± 37.11% of
control; P = 0.080, paired t-test, t = −2.331; n = 5). Figure 3A
shows, from the same animal, reported in Figure 2A, the first
10 reflexes elicited in three hindlimb muscles by a train of
rectangular pulses (100 µs) at 40 Hz. The cumulative amplitude
of all 2,000 motor reflexes evoked from bilateral TA and left
GM by electrical stimulation is significantly increased through
the administration of 5 µM of DPCPX (Figure 3E; P = 0.046,
paired t-test, t = −2.861; n = 5). Figure 3F illustrates that,
in five animals, increasing concentrations of DPCPX (from
1 to 100 µM) further augments the cumulative amplitude
of motor responses in a dose-response manner, reaching a
plateau at the highest concentrations tested (263.36 ± 84.76%
and 279.16 ± 119.08% to control, for 50 µM and 100 µM,
respectively; P = 0.044, Kruskal–Wallis one-way ANOVA on
ranks followed by post hoc multiple comparisons vs. DPCPX
1 µM group with Dunn’s method, n = 5, 5, 5, 5, 4). Surprisingly,
the first motor response evoked by a suprathreshold electrical
stimulus applied to the spinal cord (duration = 0.1 ms;
intensity = 0.78 ± 0.26 mA) was unaffected by 5 µM of
DPCPX, as were the mean latency (5.44 ± 0.85 ms) and the
mean peak to peak amplitude (0.50 ± 0.23 mV) of pooled
data from five experiments. In the presence of DPCPX (5
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FIGURE 2 | Repetitive epidural stimuli elicit responses that are rhythmically
modulated in amplitude. (A) A train of 10 stimuli applied to the cord (L5 spinal
level) at 40 Hz evokes EMG reflexes from bilateral tibialis anterior (TA) and left
gastrocnemius (GM) muscles. (B) The Mean time-course of the amplitude of
responses over the entire length of a stimulation protocol (2,000 stimuli at
40 Hz) in five animals. (C) Magnification of the time-course in (B) draws
responses to the first 300 stimuli (from the 50th to the 350th). (D)
Magnification of the time-course in (B) shows the profile of peaks of the last
200 responses with their SD (from the 1,800th to the 2,000th). (E) The power
spectrum of the mean time-course for five animals illustrates the rhythmic
components of an oscillatory pattern of modulation of the peak amplitude
throughout the entire stimulation protocol.
µM), the average time-course of peak amplitudes showed a
trend of higher responses compared to control during the first
300 pulses from the beginning of stimulation (Figures 3B,C
mean amplitude = 0.24± 0.04 mV in control vs. 0.33± 0.12 mV;
P = 0.006, paired t-test, t = −5.240; n = 5). Moreover, with
respect to control, multiple motor responses of higher amplitude
appeared for the entire duration of the stimulation protocol
(Figures 3B,D). Notably, the mean amplitude of the last two
hundred responses in the presence of DPCPX (5 µM) was
significantly higher than the last two hundred responses in
control (181.77 ± 50.52%; P = 0.037, paired t-test, t = −3.088;
n = 5). Figure 3G presents sample traces of recovering reflex
responses evoked by the last ten stimuli of the train from the
same experimental animal as in control and after administration
of DPCPX (5 µM).
The power spectrum of the spontaneous amplitude of
oscillations throughout the entire protocol demonstrated the
presence of a rhythmic pattern of modulation with a frequency
component equal to 1.29 ± 0.51 Hz, as reported in control
(Figure 3H; P = 0.667, Paired t-test, t = 0.464; n = 5) and with
an unchanged amplitude of 0.0036± 0.0031 mV/Hz2 (Wilcoxon
signed-rank test, P = 0.063; n = 5). However, following the
administration of DPCPX (5 µM), the frequency spectrum was
more populated by multiple harmonics at higher frequencies
(around 3, 7, 13, and 19 Hz). Moreover, in the presence of
DPCPX (5 µM), the power spectrum magnitude of rhythmic
modulation significantly increased, as expressed by RMS equal
to 0.32± 0.21 (P = 0.043, Paired t-test, t = 2.935; n = 5).
Overall, blockage of the adenosine A1 receptor subtype in
combination with continuous electrical stimulation of the spinal
cord increased the magnitude of the endogenous modulation
pattern and postponed the decay of responses that, in fact,
periodically appeared higher during the entire protocol.
In contrast, the selective A2 antagonist, DMPX, did not
affect the amplitude of spinally-evoked EMG responses at any
of the concentrations tested (from 1 to 100 µM; P = 0.995,
Kruskal–Wallis one-way ANOVA on Ranks; n = 3).
An Acute Transection Reduced the
Amplitude of EMG Responses to Trains of
Consecutive Pulses
In five animals, an acute transection of the spinal cord at the
low thoracic level did not affect motor responses to single
epidural pulses applied below the lesion site (duration = 0.1 ms;
intensity = 1.34 ± 0.44 mA). When compared to intact control
responses, spinal reflexes elicited by single suprathreshold
stimuli, after acute injury, showed unchanged mean latency
(5.29 ± 1.04 ms; P = 0.738, t-test, t = 0.343; n = 8, 5) and
mean amplitude (0.43 ± 0.26 mV; P = 0.549; t-test, t = 0.618;
n = 8, 5). In Figure 4A, in a representative animal, the
first ten reflexes elicited by a train at 40 Hz were derived
from three muscles. Although spinal reflexes to the first pulse
seemed unaffected by transection, they showed more frequent
failures to the following nine stimuli (Figure 4A). To further
explore responses to repetitive stimulation after an acute spinal
transection, consecutive motor responses were induced by
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FIGURE 3 | 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) augments reflex amplitude during repetitive stimulation. (A) For the same animal as in Figure 1A, DPCPX
5 µM increases the amplitude of reflexes elicited from bilateral tibialis anterior (TA) and left gastrocnemius (IGM) muscles by a train of 10 stimuli applied to the cord
(L5 spinal level) at 40 Hz. (B) Mean time-course of the amplitude of responses over the entire length of a stimulation protocol (2,000 stimuli at 40 Hz) in combination
with DPCPX (5 µM) in five animals (same animals of Figure 2). (C) Magnification of the time-course in (B) plots responses to the first 300 stimuli (from the 50th to the
350th). (D) Magnification of the time-course in (B) shows the profile of peaks of the last 200 responses (from the 1,800th to the 2,000th). (E) Scatter plot of paired
data reports the statistical increase of the cumulative amplitude of EMG responses elicited in five experiments by DPCPX (5 µM) during the entire electrical
stimulation protocol (*P = 0.046; each pair of dots represent a single animal, while the average values are in magenta; n = 5). (F) Cumulative dose-response of the
effect of DPCPX (1–100 µM) in augmenting the cumulative amplitude of EMG reflexes elicited by 2,000 stimuli at 40 Hz. Data are pooled from five animals. Data are
expressed as a percentage (%) of the respective untreated controls (*P = 0.044). (G) Sample traces from the same animal in Figure 2A comparing responses from
bilateral TAs and lGM to the last 10 stimuli of the protocol (from 1,990th to 2,000th stimuli) in control (left) and DPCPX (5 µM; right). (H) The power spectrum of the
mean time-course for five animals (as in Figure 2) illustrates the rhythmic components of the oscillatory pattern of modulation of the peak amplitude throughout the
entire stimulation protocol.
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delivering a train of pulses (2,000 stimuli, 40 Hz). In Figure 4B,
the average time-course of peak amplitudes was traced from five
experiments. Compared to intact animals, consecutive reflexes
significantly faded away faster during the first 300 stimuli (7.5 s of
stimulation; Figures 4B,C; 44.63± 22.57% to control; P = 0.005,
t-test, t = 3.810; n = 5) and were completely abolished after
approximately the 800th pulse (∼25 s of stimulation) under
continuous stimulation at the same intensity (Figures 4B,D).
Collectively, the mean cumulative amplitude of all 2,000 motor
reflexes evoked by the stimulation protocol in injured spinal
cords is significantly lower concerning intact control spinal cords
(51% of intact controls; P = 0.045; Mann–Whitney rank-sum
test; n = 8, 5).
The power spectrum of the mean time-course was largely
suppressed (RMS = 0.077 ± 0.02; n = 5; Figure 4E), but still
displayed a single principal component of modulation that is
equal to intact controls (1.41± 0.33 Hz, n = 5), albeit of negligible
amplitude (0.00002± 0.0002 mV/Hz2; n = 5).
In summary, in contrast to intact animals, after an acute
transection, the magnitude of motor response modulation to
repeated ESS was abolished within the first few seconds (typically,
less than 10 s) from stimulation onset, with the amplitude
scarcely modulated by the endogenous rhythmic pattern.
The Selective A1 Competitive Antagonist,
DPCPX Did Not Affect the Motor Output
Induced by Electrical Stimulation
Immediately Following Spinal Transection
In the current study, we reported that DPCPX augmented the
amplitude of repetitive responses in intact animals. Moreover,
we indicated that, after an acute spinal transection, the motor
output elicited by a train of pulses was dramatically reduced. To
verify whether the selective antagonism of A1 receptors could
rescue motor reflexes immediately following spinal transection,
increasing concentrations of DPCPX were applied to the
lumbosacral cord below the level of transection. However, no
differences were revealed in the cumulative amplitude of reflexes,
even at higher DPCPX concentrations (50–100 µM; P = 0.953;
Kruskal–Wallis one-way ANOVA on Ranks; n = 5), following
transection when compared to baseline responses.
DISCUSSION
Despite the promise of ESS in subjects with SCI (Angeli et al.,
2018; Gill et al., 2018; Wagner et al., 2018), variability in
patient responses and sub-restorative levels of improvement
indicate the need for the development of co-therapies to
improve the clinical efficacy of ESS therapy. Combining spinal
electrical neuromodulation with pharmacological approaches
presents an appealing mechanism to augment the effectiveness
of neurorehabilitation. Here, we demonstrate that selective
pharmacological blockage of A1 subtype adenosine receptors
during spinal electrical stimulation facilitates sensorimotor
networks in the intact spinal cord. A1 inhibition results in an
increased magnitude of an endogenous pattern that modulated
FIGURE 4 | An acute transection perturbs the peak amplitude of repetitive,
spinally-induced reflexes. (A) After transection of the cord (Th 10/11), a train
of 10 stimuli applied to the cord (L5 spinal level) at 40 Hz evokes EMG
reflexes from bilateral tibialis anterior (TA) and left gastrocnemius (GM)
muscles. (B) Mean time course of the amplitude of responses over the entire
length of a stimulation protocol (2,000 stimuli at 40 Hz). Data pooled from five
animals with a transected spinal cord. (C) Magnification of the time-course in
(B) draws responses to the first 300 stimuli (from the 50th to the 350th). (D)
Magnification of the time-course in (B) shows the profile of peaks of the last
200 responses (from the 1,800th to the 2,000th). (E) The power spectrum of
the mean time-course for five animals illustrates the rhythmic components of
an oscillatory pattern of modulation of the peak amplitude throughout the
entire stimulation protocol.
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spinally-evoked motor potentials and sustained duration of
ESS-induced activity.
Motor Output to Epidural Stimulation Is
Affected by an Endogenous Pattern of
Modulation
In the clinic, repetitive ESS with a train of electrical pulses
has been applied at different frequencies to elicit distinct
types of motor recovery in select groups of young adults
with chronic and complete SCI (Barolat et al., 1986; Jilge
et al., 2004; Minassian et al., 2007; Harkema et al., 2011;
Grahn et al., 2017). This pattern of stimulation elicits a series
of spinally-evoked motor potentials, which are, in nature,
similar to spinal reflexes from hindlimb muscles (Sayenko
et al., 2014; Hofstoetter et al., 2018). However, the response
to each delivered pulse can be periodically modulated during
repetitive spinal stimulation of the same frequency and intensity
(Hofstoetter et al., 2015; Sayenko et al., 2019). Similarly, here
we demonstrate that the amplitude of spinally-induced reflexes
can vary stochastically during repetitive epidural stimulation in
fully anesthetized animals. These fluctuations of peak responses
have also been observed previously in anesthetized animals that
were continuously subjected to pulses train at a subthreshold
intensity and lower frequency (i.e., 0.3 Hz) than those used in
this study (Taccola et al., 2020a). Based on this evidence, we
recently postulated that an endogenous pattern of modulation of
the motor output originates from spinal networks (Taccola et al.,
2020a). Present data corroborate that an endogenous pattern
of modulation of spinally-induced reflexes occurs in response
to a stimulation protocol that replicates the characteristics
of a standard clinical ESS procedure (40 Hz, suprathreshold
intensity). Moreover, power spectral density analysis of the reflex
peaks’ time-course shows that repetitive spinally-evoked motor
potentials are rhythmically modulated. Indeed, we consistently
observed that the main component of the periodic pattern
of modulation was more pronounced in amplitude every
∼50 stimuli, which is at ∼0.8 Hz. A similar endogenous
sinusoidal pattern originating from spinal circuits has been
reported during rhythmic modulation of the amplitude of motor
output in behaving cats (Cuellar et al., 2009).
It remains to be seen whether the optimal frequency of
stimulation should be tuned to the intrinsic physiologic pattern
of activity to maximize the effectiveness of neuromodulation.
In particular, it is yet to be explored whether spinal
stimulation implemented by delivering trains of stimuli within
the range shown to be physiologically effective and containing
the principal components of the intrinsic physiological patterns
of modulation (Gerasimenko et al., 2005; Lavrov et al., 2006), can
modulate spinal networks to a more receptive state. Alternatively,
it remains to be explored to what extent do the failures of
stimulation to induce a response to contribute to the summation
of the membrane potential of spinal neurons, thereby affecting
spinal neuron thresholds at periodic higher frequencies.
Neurochemical Response to ESS
During training sessions in the presence of stimulation in
humans, the motor output cannot be sustained at the same
level and has been noticed to decline with the duration of the
training and stimulation (Rejc et al., 2017; Gill et al., 2018;
Sayenko et al., 2019). Multiple factors can contribute to this
decline of a patient’s performance, including cardiovascular
and muscle fatigue which are proportionally dependent on
the duration and amount of motor activity. However, this
decline of performance must also be considered in the
context of neurochemical responses to ESS. It is critical to
note that spinal stimulation drives multiple responses. For
example, spinal stimulation simultaneously facilitates the release
of many neurotransmitters and neuromodulators because of
the different synapses encountered by the electrical field
in the spinal cord (Taccola et al., 2018). This increase of
neurotransmitters and neuromodulators acts at the synaptic
milieu of multiple network sites, including their release
from the same Ia afferents that were involved during a
continuous repetitive stimulation (Kuno, 1964; Hofstoetter et al.,
2019). Through this release of multiple neurotransmitters and
neuromodulators, ESS might mimic the physiological changes in
the chemical environment of the spinal cord during rhythmic
activities (e.g., locomotion) or lead to synaptic ‘‘fatigue’’ and
induction of receptor sensitization (Taccola et al., 2018). In
the current study, the amplitude of muscle responses to 40 Hz
stimulation of suprathreshold intensity decreased until full
response abolishment occurred after less than 45 s. This fact
is reminiscent of the spontaneously decaying locomotor-like
oscillations evoked by electrical stimulation in the isolated
spinal cord, even during the continuous delivery of pulses
(Marchetti et al., 2001b). This failure has been ascribed to
presynaptic mechanisms associated with a diminished release
of glutamate during prolonged stimulation. Besides, at the
postsynaptic level, a membrane shunt determined by a local
increase of potassium concentrations in the extracellular milieu
should also be considered (Marchetti et al., 2001a). Further, the
release of inhibitory neurotransmitters triggered by continuous
stimulation can contribute to the decay of responses (Dale
and Gilday, 1996). The present results indicate that, although
a strong suppression of spinally-induced reflexes occurs after
∼45 s of the stimulation protocol, a brief 5-min rest was
sufficient to promote the reemergence of suprathreshold motor
responses between repetitions. This prompt recovery of the
evoked motor output helps to explain the efficacy of burst
spinal cord stimulation over the 40 Hz ‘‘gold standard’’ used
for spinal stimulation protocols in experimental animal models
(Taccola, 2011; Meuwissen et al., 2019; Taccola et al., 2020a).
Indeed, when trains of stimuli (e.g. 60 s) were repetitively
applied over a long time frame (e.g., 45 min) to spinal cords
isolated from neonatal rats, 2-min pauses appeared necessary
to equally activate spinal circuits for locomotion (Dingu et al.,
2016). The self-limiting properties of the spinal circuits that
process repetitive pulses indicate the need to include periodic
pauses during continuous ESS to maximize the expression of
motor responses.
The facilitatory effect of the A1 antagonist on the amplitude of
motor output illustrated in the current study is explained by two
tentative mechanisms. First, DPCPX selectively blocks inhibitory
presynaptic receptors on primary afferents to maximize input
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delivery. Second, the antagonism of postsynaptic A1 receptors
depressing the activity of spinal networks (Witts et al., 2015)
might increase the excitability of the spinal cord, in turn,
maximizing the magnitude of motor output.
An Acute Spinal Transection Depresses
the Response of Repetitive Spinal Cord
Stimulation
In the present study, although DPCPX largely increased the
yield of repetitive stimulation in intact cords, after a spinal
transection the selective antagonism of A1 receptors appeared
to be ineffective. This can be in line with the contrasting
and paradoxical effects of adenosine agonists and antagonists
reported in various neurodegenerative conditions (Stone et al.,
2009). For instance, a previous study showed a massive release
of adenosine right after a spinal lesion (McAdoo et al.,
2000), and adenosine is putatively able to compete with
DPCPX at A1 receptor sites. In our study, an acute spinal
cord transection affected the amplitude of reflexes evoked
by repetitive stimulation. Moreover, the endogenous pattern
of modulation was largely silenced immediately after spinal
transection, without the periodic appearance of higher peaks
that occur in intact cords under the stimulation protocol.
Following an acute SCI, a period of several hours to a few
weeks has been reported both in humans and in animals
(Lavrov et al., 2008), wherein electrophysiological signals, such
as spinal reflexes, are depressed (Ditunno et al., 2004). The
mechanisms of this reduced neural activity remain poorly
understood. At the same time, although the existence of an
acute period of spinal shock in rats has been reported after
severe spinal contusions (Taccola et al., 2020b) it is rarely
the case immediately after complete surgical transection of the
cord conducted under full anesthesia (Coskun et al., 2010).
Our study demonstrates that spinal reflexes in response to
single epidural pulses remain unaffected by spinal transection,
similar to what has been reported in awake rats (Lavrov
et al., 2006). However, the responses to repetitive stimuli were
reduced. We can speculate that the transection of descending
and propriospinal projections reduces the extent of lumbar spinal
circuits by interrupting reverberating polysynaptic pathways
possibly involved in the modulation of repetitive responses. Still,
whether similar effects are also present in chronic injuries needs
to be demonstrated.
CONCLUSIONS
In the current study, we further explore how the amplitude
of motor responses evoked by repetitive pulses applied to a
rodent spinal cord is modulated by the endogenous spinal
rhythm (Taccola et al., 2020b). This endogenous pattern of
modulation is different from the central pattern generator
for locomotion (Dimitrijevic et al., 1998) since it has not
been able, per se, to generate any coordinated motor activity
from hindlimb muscles. Rather, it can be speculated that
the endogenous pattern of modulation represents an intrinsic
and rhythmic tone able to set the subthreshold excitability of
propriospinal circuits (Taccola et al., 2020a). At the cellular level,
it should be viewed as synchronized spontaneous oscillations
occurring in the resting potentials of circuit elements that do
not reach the threshold for triggering an action potential, but
which can still summate incoming external input. Synchronized
subthreshold changes in membrane potentials spontaneously
occur in microcircuits in vitro (Lampl and Yarom, 1993;
Lefler et al., 2020). It seems imperative now to explore if a
similar pattern of modulation can be found in the human
spinal cord. This information will help better define the whole
duration of each ESS session and tune the frequency of
neuromodulating paradigms, thereby increasing the extent of
motor recovery. Although in the current study, DPCPX was
unable to facilitate neuromuscular response during spinal cord
stimulation in acute spinal cord transected rats, this is likely due
to temporary ionic disruption of spinal networks. Future research
should include additional preclinical studies in chronically
injured animals to elucidate a potential role of the selective
pharmacological A1 antagonism in maximizing the recovery
of motor output during ESS and compare the effects with
previously used pharmacological neuromodulation agents within
the same protocol. Also, spinal electrical neuromodulation has
recently received great attention as an innovative rehabilitation
tool for several neuromotor conditions that do not affect the
spinal cord directly, such as multiple sclerosis (Illis et al.,
1980), Parkinson’s disease (Santana et al., 2014; de Andrade
et al., 2016; Samotus et al., 2018; de Souza et al., 2018), and
cerebellar ataxia (Solopova et al., 2017). For these pathologies,
A1 antagonists are a potential new avenue for restoring
sensorimotor functions in the presence of spinal stimulation. At
the same time, more detailed and intensive preclinical studies are
needed to investigate dosage, optimize methods of delivery, and
potential systemic effects and precautions, before the synergistic
application of A1 antagonists and spinal stimulation is translated
to clinic.
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